CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL
$82,604N01FY2025DANIH
Albany Molecular Research, Inc., Albany NY
Investigators
Abstract
The overall objective of this project is for the contractor to support the chemistry, manufacturing, and controls (CMC) development of NCGC00413972 for preclinical safety evaluation and clinical trial. Rare Diseases
View original record on NIH RePORTER →